Attending this event?
Back To Schedule
Wednesday, June 22 • 4:15pm - 5:15pm
#372: Accelerating Innovation Through Investing

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-22-640-L04-P ; CME 1.00; RN 1.00

This forum delves into the state of strategic investments from both pharmaceutical venture teams and institutional investors, exploring best practices to collectively advance research and care.

Learning Objectives

Examine the current status of pharma venture in accelerating innovation; Discuss the opportunities and challenges of these strategic investments; Describe examples of what worked and what didn't to inform future investments and partnerships.


Dana Callow, MBA


Rana Lonnen, PhD, MBA

Tyrell Rivers, PhD, MBA

Michael McInerney


Dana Callow

Founding Partner, Boston Millennia Partners, United States
Mr. Callow is the Managing Partner of Boston Millennia Partners. He was Lead Director of PAREXEL International Corp., a clinical trials management company sold on in 2017 for $5 billion. He has served as a Director of a number of other public and private companies, including ILEX... Read More →

Rana Lonnen

Managing Director, dRx Capital, Novartis, Switzerland

Michael McInerney

Head of Digital Health Business Development, Bristol-Myers Squibb Company, United States
Michael is an Executive Director leading Digital Health within the Business Development Innovative Technologies function at Bristol Myers Squibb. Michael is responsible for evaluation and execution of Business Development transaction in support of Digital Innovation priorities at... Read More →

Tyrell Rivers

Executive Director, Corporate Development and Ventures, AstraZeneca, United States

Wednesday June 22, 2022 4:15pm - 5:15pm CDT
Room 186 McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616
  07: ProjectManagement-StrategicPlanning, Forum